OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based classification of tauopathies
Yang Shi, Wenjuan Zhang, Yang Yang, et al.
Nature (2021) Vol. 598, Iss. 7880, pp. 359-363
Open Access | Times Cited: 619

Showing 1-25 of 619 citing articles:

Cryo-EM structures of amyloid-β 42 filaments from human brains
Yang Yang, Diana Arseni, Wenjuan Zhang, et al.
Science (2022) Vol. 375, Iss. 6577, pp. 167-172
Open Access | Times Cited: 352

Structures of α-synuclein filaments from human brains with Lewy pathology
Yang Yang, Yang Shi, Manuel Schweighauser, et al.
Nature (2022) Vol. 610, Iss. 7933, pp. 791-795
Open Access | Times Cited: 279

The expanding amyloid family: Structure, stability, function, and pathogenesis
M.R. Sawaya, Michael P. Hughes, José A. Rodríguez, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4857-4873
Open Access | Times Cited: 272

The molecular basis for cellular function of intrinsically disordered protein regions
Alex S. Holehouse, Birthe B. Kragelund
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 187-211
Open Access | Times Cited: 235

Structure of pathological TDP-43 filaments from ALS with FTLD
Diana Arseni, Masato Hasegawa, Alexey G. Murzin, et al.
Nature (2021) Vol. 601, Iss. 7891, pp. 139-143
Open Access | Times Cited: 211

Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy
Sofia Lövestam, Fujiet Adrian Koh, Bart van Knippenberg, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 206

Tauopathies: new perspectives and challenges
Yi Zhang, Kaimin Wu, Yang Liu, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 187

Age-dependent formation of TMEM106B amyloid filaments in human brains
Manuel Schweighauser, Diana Arseni, Mehtap Bacioglu, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 310-314
Open Access | Times Cited: 144

Cellular and pathological heterogeneity of primary tauopathies
Dah‐eun Chloe Chung, Shanu F. Roemer, Leonard Petrucelli, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 140

Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
Yi Jiang, Qin Cao, M.R. Sawaya, et al.
Nature (2022) Vol. 605, Iss. 7909, pp. 304-309
Open Access | Times Cited: 125

Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts
Ann C. McKee, Thor D. Stein, Bertrand R. Huber, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 371-394
Open Access | Times Cited: 122

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1954-1963
Open Access | Times Cited: 120

Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Sjors H. W. Scheres, Benjamin Falcon, Michel Goedert
Nature (2023) Vol. 621, Iss. 7980, pp. 701-710
Closed Access | Times Cited: 115

Tau liquid–liquid phase separation in neurodegenerative diseases
Solomiia Boyko, Witold K. Surewicz
Trends in Cell Biology (2022) Vol. 32, Iss. 7, pp. 611-623
Open Access | Times Cited: 113

Mechanisms and pathology of protein misfolding and aggregation
Nikolaos Louros, Joost Schymkowitz, Frédéric Rousseau
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 12, pp. 912-933
Closed Access | Times Cited: 113

Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases
Andrew Chang, Xinyu Xiang, Jing Wang, et al.
Cell (2022) Vol. 185, Iss. 8, pp. 1346-1355.e15
Open Access | Times Cited: 110

Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 107

2.7 Å cryo-EM structure of ex vivo RML prion fibrils
Szymon W. Manka, Wenjuan Zhang, Adam Wenborn, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 107

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
Pedro Magalhães, Hilal A. Lashuel
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 96

Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers
Todd E. Golde
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 209-227
Open Access | Times Cited: 86

Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Adam L. Boxer, Reisa A. Sperling
Cell (2023) Vol. 186, Iss. 22, pp. 4757-4772
Open Access | Times Cited: 82

Disease-specific tau filaments assemble via polymorphic intermediates
Sofia Lövestam, David Li, Jane L. Wagstaff, et al.
Nature (2023) Vol. 625, Iss. 7993, pp. 119-125
Open Access | Times Cited: 79

Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases
Dan Li, Cong Liu
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 9, pp. 523-534
Closed Access | Times Cited: 78

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
Shanu F. Roemer, Lea T. Grinberg, John F. Crary, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 4, pp. 603-614
Open Access | Times Cited: 78

Page 1 - Next Page

Scroll to top